// App-Quantinova.ai

1414 : Treatment outcome under cetuximab-based therapy and individual ADCC capability in head and neck cancer

Researchers

Presenter

  • Cristiana Lo Nigro

Principal Investigators

  • Laura Lattanzio

  • Daniela Vivenza

  • Martino Monteverde

  • Federica Tonissi

  • Giuliana Strola

  • Marco Merlano

  • Gerard Milano

Medical Centers

  • S. Croce & Carle Teaching Hospital, Cuneo, Italy

  • Centre Antoine-Lacassagne, Nice, France

Locations

  • France

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

  • Solid malignancies

Biomarkers

  • Natural Killer cells

  • Epidermal growth factor receptor

Drug/Treatment

  • Erbitux

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved